Related Experiment Video

Updated: Jul 6, 2026

Experimental Endocarditis Model of Methicillin Resistant Staphylococcus aureus (MRSA) in Rat
07:46

Experimental Endocarditis Model of Methicillin Resistant Staphylococcus aureus (MRSA) in Rat

Published on: June 4, 2012

[New anti-Gram+antibiotics: which role in infective endocarditis?]

A Makinson1, V Le Moing

  • 1Maladies infectieuses et tropicales, hôpital Gui-de-Chauliac, CHRU de Montpellier, 80, avenue Augustin-Fliche, 34295 Montpellier cedex 5, France.

Annales De Cardiologie Et D'Angeiologie
|April 9, 2008
PubMed

Insights

New antibiotics show promise for treating infections, but their effectiveness in infective endocarditis requires further study. Daptomycin is currently recommended for specific methicillin-resistant Staphylococcus aureus cases when vancomycin is unsuitable.

Area of Science:

  • Infectious Diseases
  • Pharmacology
  • Cardiology

Background:

  • Antibiotic resistance is a growing global concern, impacting treatment strategies for bacterial infections.
  • Methicillin-resistant Staphylococcus aureus (MRSA) presents significant treatment challenges, despite lower prevalence in France.
  • Several novel antibiotics, including daptomycin, are emerging with potential applications in infectious disease management.

Purpose of the Study:

  • To evaluate the current and potential roles of new antibiotic agents in managing infections.
  • To specifically assess the utility of novel antibiotics in the context of infective endocarditis.
  • To define the current indications for specific antibiotic use in methicillin-resistant Staphylococcus aureus infections.

Main Methods:

  • Literature review of recent antibiotic approvals and clinical data.
  • Analysis of antibiotic efficacy in various acute infection models.
  • Clinical guideline review for infective endocarditis treatment.

Main Results:

  • New antibiotics like quinupristin-dalfopristin, linezolid, tigecycline, daptomycin, ceftobiprole, and dalbavancin are available or forthcoming.
  • The role of these new agents in acute infections is documented, but their efficacy in infective endocarditis is not yet established.
  • Daptomycin, often with rifampicin, is currently indicated for right-sided MRSA endocarditis when vancomycin cannot be used.

Conclusions:

  • The therapeutic landscape for bacterial infections is evolving with new antibiotic options.
  • Further research is crucial to establish the role of novel antibiotics in treating infective endocarditis.
  • Current guidelines support daptomycin for specific MRSA endocarditis scenarios, highlighting the need for tailored treatment approaches.

More Related Videos

Generating Transposon Insertion Libraries in Gram-Negative Bacteria for High-Throughput Sequencing08:19

Generating Transposon Insertion Libraries in Gram-Negative Bacteria for High-Throughput Sequencing

Published on: July 7, 2020

Related Concept Videos

Endocarditis I: Introduction01:25

Endocarditis I: Introduction

Introduction:Endocarditis is the infection of the endocardium, the inner lining of the heart and its valves. When the heart muscle is involved, the condition is termed myocarditis, while an infection of the outer lining is called pericarditis. Infective endocarditis (IE) primarily affects the endocardium, where pathogens adhere to the valves or lining, forming vegetation that can lead to severe complications. Infective endocarditis occurs when microorganisms, usually bacteria from other body...
Endocarditis III: Medical Management01:18

Endocarditis III: Medical Management

Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
Endocarditis IV: Nursing Management01:29

Endocarditis IV: Nursing Management

Infective endocarditis (IE) is a chronic infection of the heart's endocardium, primarily affecting the heart valves. A detailed nursing assessment for a patient with IE involves collecting subjective and objective data to ensure an accurate diagnosis and timely intervention.Subjective DataThe nurse gathers information about the patient's symptoms and complaints during the subjective assessment. Patients with infective endocarditis often report non-specific symptoms that can mimic other...
Inhibitors of Gram-positive Cell Wall Synthesis01:23

Inhibitors of Gram-positive Cell Wall Synthesis

Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
Endocarditis II: Clinical Features of Infective Endocarditis01:25

Endocarditis II: Clinical Features of Infective Endocarditis

Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...